[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Musumeci et al., 2012 - Google Patents

G-quadruplex-forming oligonucleotide conjugated to magnetic nanoparticles: synthesis, characterization, and enzymatic stability assays

Musumeci et al., 2012

View HTML
Document ID
2123242560969059787
Author
Musumeci D
Oliviero G
Roviello G
Bucci E
Piccialli G
Publication year
Publication venue
Bioconjugate chemistry

External Links

Snippet

In the present work, we report the conjugation of superparamagnetic nanoparticles to a fluorescently labeled oligodeoxyribonucleotide (ODN) able to fold into stable unimolecular guanine quadruple helix under proper ion conditions by means of its thrombin-binding …
Continue reading at www.ibb.cnr.it (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Musumeci et al. G-quadruplex-forming oligonucleotide conjugated to magnetic nanoparticles: synthesis, characterization, and enzymatic stability assays
Li et al. Modulating aptamer specificity with pH-responsive DNA bonds
Musumeci et al. Fluorescence sensing using DNA aptamers in cancer research and clinical diagnostics
Radom et al. Aptamers: molecules of great potential
Willis et al. Liposome-anchored vascular endothelial growth factor aptamers
Tokunaga et al. Cell surface-anchored fluorescent aptamer sensor enables imaging of chemical transmitter dynamics
Chen et al. DNA micelle flares for intracellular mRNA imaging and gene therapy
Ren et al. In situ siRNA assembly in living cells for gene therapy with microRNA triggered cascade reactions templated by nucleic acids
Yigit et al. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles
Li et al. 3D DNA scaffold-assisted dual intramolecular amplifications for multiplexed and sensitive microRNA imaging in living cells
Labib et al. Electrochemical sensing of aptamer-facilitated virus immunoshielding
Tavitian In vivo imaging with oligonucleotides for diagnosis and drug development
Li et al. Precision spherical nucleic acids enable sensitive FEN1 imaging and controllable drug delivery for cancer-specific therapy
Lei et al. Nature-inspired smart DNA nanodoctor for activatable in vivo cancer imaging and in situ drug release based on recognition-triggered assembly of split aptamer
Gong et al. PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging
Liu et al. α-l-Threose nucleic acids as biocompatible antisense oligonucleotides for suppressing gene expression in living cells
Riccardi et al. Fluorescent thrombin binding aptamer-tagged nanoparticles for an efficient and reversible control of thrombin activity
Rouge et al. Spherical nucleic acids as a divergent platform for synthesizing RNA–nanoparticle conjugates through enzymatic ligation
Zou et al. Fluorinated DNA micelles: synthesis and properties
McConnell et al. In vivo use of a multi-DNA aptamer-based payload/targeting system to study dopamine dysregulation in the central nervous system
Yang et al. An autonomous self-cleavage DNAzyme walker for live cell microRNA imaging
Wang et al. Self-assembled DNA–PEG bottlebrushes enhance antisense activity and pharmacokinetics of oligonucleotides
Gubu et al. Nucleic acid amphiphiles: synthesis, properties, and applications
Li et al. Nucleolin-targeted DNA nanotube for precise cancer therapy through forster resonance energy transfer-indicated telomerase responsiveness
Chen et al. DNA-supramolecule conjugates in theranostics